01527oam 2200433Ia 450 991069877160332120090406142301.0(CKB)5470000002396139(OCoLC)317883427(OCoLC)995470000002396139(EXLCZ)99547000000239613920090406d2008 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] S1C(R2) dose selection for carcinogenicity studiesSilver Spring, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research ;[Rockville, MD] :Center for Biologics Evaluation and Research,[2008]i, 10 pages digital, PDF fileTitle from PDF title page (viewed on Apr. 6, 2009)."ICH.""Revision 1.""September 2008."Guidance for industry DrugsDosageCarcinogenicity testingDrugsDosage.Carcinogenicity testing.Center for Drug Evaluation and Research (U.S.)Center for Biologics Evaluation and Research (U.S.)International Conference on Harmonisation.GPOGPOGPOBOOK9910698771603321Guidance for industry3434577UNINA